Mike Schmitt is a board-certified medical oncologist and Senior Medical Director at Pfizer, leading global oncology clinical development. Educated at the University of Washington, his expertise spans from pre-clinical research to Phase 3 trials across ADCs, immunotherapy, and small molecules, with previous leadership roles at Seagen.
Alongside his industry role, Mike maintains a part-time clinical practice at the U. S. Department of Veterans Affairs, where he treats patients with solid tumors and hematologic malignancies. He also dedicates time to teaching and supervising oncology fellows, demonstrating a passion for mentorship and patient care.
He is the co-founder of TwinStrand Biosciences and co-inventor of the foundational Duplex Sequencing technology, which has been widely adopted in the industry.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.